key: cord-0732069-gcryvrud
authors: Lesort, Cécile; Fattouh, Kinda; Jullien, Denis; Kanitakis, Jean
title: A recent nodule on the forehead
date: 2021-05-14
journal: Eur J Dermatol
DOI: 10.1684/ejd.2021.3980
sha: e90be127a4d03011b7819c0f3e0a47f5d2863165
doc_id: 732069
cord_uid: gcryvrud

nan

A 69-year-old Caucasian man with a past history of systemic vasculitis treated with rituximab and cyclophosphamide, as well as several cutaneous keratinocytic carcinomas treated by surgical excision, presented with a cutaneous lesion on the forehead that had appeared one month prior to consultation and was increasing in size. Clinical examination revealed a 0.8-cm, well-defined, redbrown keratotic nodule ( figure 1A) . Dermoscopy revealed figure 1D ) and focal, heterogeneous expression of epithelial membrane antigen; they did not express keratin 15 or CD34 antigen. These features were suggestive of trichilemmal carcinoma. Trichilemmal carcinoma (TC), also known as tricholemmal carcinoma and trichilemmocarcinoma, is a rare cutaneous adnexal tumour first described by Headington in 1976 [1] , and represents the malignant counterpart of trichilemmoma.

Hamman et al. [2] reviewed, in 2014, all the 103 reported TC cases. TC develops mainly on sun-exposed skin in elderly patients, most often on the scalp, forehead and neck. It usually manifests as a single lesion and may be ulcerated, mimicking basal cell carcinoma, squamous cell carcinoma, keratoacanthoma or amelanotic melanoma. It can also present as an indurated erythematous plaque.

Histological examination [3] shows intradermal cell proliferation, composed of multiple lobules connected to the epidermis with a pushing lower border. Tumour cells are polygonal, with abundant, eosinophilic, often clear, glycogen-rich cytoplasm. They form nests showing trichilemmal keratinization and a peripheral palisading pattern, indicating the follicular outer root sheath origin of the tumour (absence of granular layer). Cytologic atypia and high mitotic activity are frequent. Hyperkeratosis, parakeratosis, dyskeratotic cells and pagetoid intraepidermal spread are variably present. Actinic damage is generally associated. Despite a malignant cytological appearance, the clinical course of TC is usually indolent. The recommended treatment is surgical excision with clear margins [4] . Recurrence has been reported, and was also treated with surgical excision. Rare cases of local lymph node or distant metastases have been reported [5] . Various chemotherapy agents have been used, such as cisplatin, 5-fluorouracil, vindesine, and cyclophosphamide, but the prognosis of metastatic TC is poor.

A 75-year-old female patient was referred to the urgent dermatology service by her general practitioner (GP). She described an erythematous rash which had first appeared five days prior. The rash initially developed on the neck and then spread to include the arms, chest, back and groin. She described some pruritus, although not as a prominent feature, and some coryzal symptoms, but no fever. Just over two weeks prior to the rash appearing, she had been prescribed prednisolone by her GP at a dose of 60 mg once daily for presumed giant cell arteritis. She had been referred to the rheumatology team for assessment, but had not yet been reviewed. Her past medical history included fibromylagia, asthma and hay fever. Her regular medication included cetirizine, dosulepin, fluoxetine, gabapentin, omeprazole and a combined beclometasone/formoterol inhaler. She had no known drug allergies. On examination, there was a widespread papular erythematous rash with superimposed superficial, fragile pustules, affecting the trunk, upper limbs and groin. The rash showed confluence over the chest and back (figures 1A-C). The legs and face were relatively spared on initial presentation. There was no mucosal involvement. She was apyrexial and there was no lymphadenopathy.

The clinical differential included acute generalised exanthematous pustulosis (AGEP) and pustular psoriasis. Initial blood tests were unremarkable except for a neutrophilia of 20.74 × 10 9 /L (normal: 4-11). The high dose of prednisolone likely contributed to this degree of neutrophilia, but a neutrophilia can also be seen in neutrophilic dermatoses such as AGEP. Although C-reactive protein was only 20 mg/L (normal <5) at initial presentation, this did peak at 200 mg/L on blood tests taken around two weeks after initial presentation. All regular medication was discontinued and the dose of prednisolone was reduced to 40 mg once daily, after discussion with the rheumatology team. Skin biopsies from the back and thigh were taken at initial presentation and one week later, respectively. Figure 2A shows the biopsy taken from the thigh which revealed extensive subcorneal neutrophilic pustules with intraepidermal extension. There was subepidermal vesiculation due to papillary dermal oedema in association with extravasated red blood cells. A mild superficial perivascular inflammatory cell infiltrate, composed of lymphocytes and neutrophils, was present in the underlying dermis. Eosinophils were

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a Phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy Phase III trials

Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study

Thromboembolism with Janus kinase (JAK) inhibitors for rheumatoid arthritis: how real is the risk?

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis

Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome/toxic epidermal necrolysis-ABCD-10

Tumors of the hair follicle. A review

Management of trichilemmal carcinoma: an update and comprehensive review of the literature

WHO Classification of Skin Tumors

Recurrent and metastatic trichilemmal carcinoma of the skin over the thigh: a case report

Surgical treatment of trichilemmal carcinoma